On February 17, 2023, Huang Xiaodong, Chairman of Shandong Province Pharmaceutical Industry Design Institute Co., Ltd. and his delegation visited Jerei. Jerei Vice President An Shicai and General Manager of Integration Development Center Liu Peng received them, and the two sides had a friendly discussion on the digital transformation of pharmaceutical enterprises.
(hereinafter referred to as “Shandong Medical Industrial Design Institute”) was founded in 1988, mainly engaged in pharmaceutical, pesticide, veterinary medicine, chemical, food, daily-use chemicals, logistics, new energy and other fields of consulting and design services, has won more than 100 national, provincial and ministerial-level excellent engineering design, consulting achievement awards. The company has been recognized as a national high-tech enterprise, a municipal “specialized, special and new” small and medium-sized enterprise, and a provincial-level professional design institute in the forefront of the national pharmaceutical design industry. At present, it holds Class A qualification in chemical, petrochemical and pharmaceutical industries, Class B qualification in construction industry (building engineering), Class GC1 and Class GC2 pressure piping design qualification issued by the Ministry of Construction, and has passed the ISO9001:2015 international quality system certification, and is a Class A unit of the national engineering consulting credit evaluation.
Under the environment of continuous innovation and development of the pharmaceutical industry, digital transformation has become a necessary way for pharmaceutical enterprises to improve innovation ability, efficient collaboration, reduce costs and increase efficiency, and create competitive advantages. Shandong Medical Engineering Design Institute, as one of the senior and comprehensive pharmaceutical engineering professional service providers in China, has a deep understanding of the importance of digital transformation in the new development stage of the enterprise, and this visit to Jerei is expected to explore the new mode of pharmaceutical digital cooperation through communication and interoperability.
Through this communication, Mr. Huang and his team investigated Jerei's development history, Fulima Cloud and digital twin technology, and at the same time gained a clearer understanding of Jerei's exploration in the pharmaceutical field and the innovative results it has achieved. Based on this, both parties reached a consensus on giving full play to their respective business characteristics, realizing resource sharing and complementing each other's strengths, and jointly promoting the extension and development of their products and services.
Jerei, as a digital twin-driven industrial Internet company, has always taken the pharmaceutical field as one of the important directions for the company's in-depth development, and Jerei has launched a mature and complete digital solution for the pharmaceutical industry, which helps pharmaceutical companies to accelerate research and development, improve production efficiency, reduce marketing costs, and help many pharmaceutical companies to step into the path of digital transformation.
Jerei will give full play to its own advantages, integrate digital twin resources, according to the actual situation of pharmaceutical enterprises, and continue to provide professional and reliable engineering design, consulting, general contracting integrated comprehensive solutions for industry customers, and at the same time work together with more cooperative enterprises, to continue to innovate digital technology, empowering the pharmaceutical industry digital transformation and upgrading!
